These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7713144)

  • 1. Influence of NMDA receptor ligands on thyrotropin-releasing hormone-induced scratching in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1995 Jan; 272(1):119-21. PubMed ID: 7713144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between thyrotropin-releasing hormone (TRH) and NMDA-receptor-mediated responses in hypoglossal motoneurones.
    Rekling JC
    Brain Res; 1992 Apr; 578(1-2):289-96. PubMed ID: 1354998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine receptor agonists inhibit TRH-induced behaviour in rabbits: evidence for a main role of striatal A2 receptors.
    Popoli P; Caporali MG
    Behav Brain Res; 1993 Oct; 57(1):105-9. PubMed ID: 8292250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice.
    Jafari-Sabet M; Zarrindast MR; Rezayat M; Rezayof A; Djahanguiri B
    Life Sci; 2005 Nov; 78(2):157-63. PubMed ID: 16137707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine-dependent mechanism.
    Ouagazzal A; Amalric M
    Eur J Pharmacol; 1995 Dec; 294(1):137-46. PubMed ID: 8788425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-releasing hormone (TRH)-induced facilitation of spinal neurotransmission: a role for NMDA receptors.
    Chizh BA; Headley PM
    Neuropharmacology; 1994 Jan; 33(1):115-21. PubMed ID: 8183435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex.
    Hata N; Nishikawa T; Umino A; Takahashi K
    Neurosci Lett; 1990 Nov; 120(1):101-4. PubMed ID: 1981384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat.
    Hong YG; Henry JL
    Brain Res; 1992 Jan; 569(1):38-45. PubMed ID: 1351773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists.
    Carrozza DP; Ferraro TN; Golden GT; Reyes PF; Hare TA
    Brain Res; 1992 Mar; 574(1-2):42-8. PubMed ID: 1353403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between dopamine D1 and D2 receptors in the model of thyrotropin-releasing hormone (TRH)-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1991 Aug; 201(1):11-6. PubMed ID: 1686587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in prepulse inhibition after local administration of NMDA receptor ligands in the core region of the rat nucleus accumbens.
    Reijmers LG; Vanderheyden PM; Peeters BW
    Eur J Pharmacol; 1995 Jan; 272(2-3):131-8. PubMed ID: 7713156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated pretreatment of morphine prevents morphine-induced amnesia: A possible involvement for dorsal hippocampal NMDA receptors.
    Zarrindast MR; Asadi F; Rezayof A
    Arch Iran Med; 2011 Jan; 14(1):32-8. PubMed ID: 21194259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine-like behavioral effects in pigeons induced by systemic administration of the excitatory amino acid antagonist, 2-amino-5-phosphonovalerate.
    Koek W; Woods JH; Ornstein P
    Life Sci; 1986 Sep; 39(11):973-8. PubMed ID: 2875374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of NMDA- and naloxone-induced LH release by NMDA receptor antagonist and CRH in ovariectomized estrogen-primed rats.
    Chiba A; Akema T; Nagami Y; Kimura F; Toyoda J
    Neuroendocrinology; 1997 Feb; 65(2):141-6. PubMed ID: 9067992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intrathecal glutamatergic drugs on locomotion. II. NMDA and AP-5 in intact and late spinal cats.
    Giroux N; Chau C; Barbeau H; Reader TA; Rossignol S
    J Neurophysiol; 2003 Aug; 90(2):1027-45. PubMed ID: 12904502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SCH 23390 on thyrotropin-releasing hormone-induced behaviour in rabbits.
    Popoli P; Caporali MG; Scotti de Carolis A
    Eur J Pharmacol; 1989 Dec; 173(2-3):211-3. PubMed ID: 2576229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of NMDA-type glutamate receptor agonist NMDA and antagonist D-AP-5 into the central nucleus of the amygdale alters water intake rather than food intake.
    Yan J; Yan J; Li J; Chen K; Sun H; Zhang Y; Zhao X; Sun B; Zhao S; Song L; Wei X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):595-600. PubMed ID: 22588904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ACTH(4-9) analog Org2766 modulates the behavioral changes induced by NMDA and the NMDA receptor antagonist AP5.
    Spruijt BM; Josephy M; Van Rijzingen I; Maaswinkel H
    J Neurosci; 1994 May; 14(5 Pt 2):3225-30. PubMed ID: 7910205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
    Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.